Germ cell tumor classification: Difference between revisions

Jump to navigation Jump to search
(classification)
(Classification)
Line 1: Line 1:
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
* Ovarian germ cell tumors (OGCTs ): The histologic types that arise from the ovary are similar to those arising from the testes of men
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF| Types}}
* * Embryo-like neoplasms
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Subtypes}}
* ** Teratomas and their subtypes and
! style="background: #4479BA; padding: 5px 5px;" colspan=1 | {{fontcolor|#FFFFFF|Signs and Symptoms}}
* ** Dysgerminomas
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Histopathology}}
* * Extraembryonic fetal-derived (placenta-like) cell populations
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF| Lab finding }}
* * A mixture of both.
! style="background: #4479BA; padding: 5px 5px;" colspan=1 | {{fontcolor|#FFFFFF| Treatment }}
 
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF| Prognosis}}
 
 
 
 
 
 
 
 
 
 
 
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF| Types}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Subtypes}}
! colspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Signs and Symptoms}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Histopathology}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF| Lab finding }}
! colspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF| Treatment }}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF| Prognosis}}
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="3;"|Gonadal'''
| rowspan="3;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Gonadal
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Seminoma (Testis)
Seminoma (Testis)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Painless [[testicular mass]] with discomfort
* Painless [[testicular mass]] with discomfort
* [[Back pain]]
*[[Back pain]]
* [[Abdominal discomfort]]
*[[Abdominal discomfort]]
* [[Abdominal mass]].
*[[Abdominal mass]].
| style="padding: 5px 5px; background: #F5F5F5;" |Gross: pale gray to yellow nodules that are uniform or slightly lobulated and often bulge from the cut surface
| style="padding: 5px 5px; background: #F5F5F5;" |Gross: pale gray to yellow nodules that are uniform or slightly lobulated and often bulge from the cut surface
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 25: Line 43:
* Other diagnostic studies for seminoma include [[biopsy]], [[PET|FDG-PET scan]], and [[bone scan]].
* Other diagnostic studies for seminoma include [[biopsy]], [[PET|FDG-PET scan]], and [[bone scan]].
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Orchiectomy|Radical inguinal orchiectomy]] is the first treatment for any stage of testicular seminoma. Usually done as diagnostic and therapeutic.
*[[Orchiectomy|Radical inguinal orchiectomy]] is the first treatment for any stage of testicular seminoma. Usually done as diagnostic and therapeutic.
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Prognosis]] of [[seminoma]] is good for all stages with greater than 90% cure rate.
*[[Prognosis]] of [[seminoma]] is good for all stages with greater than 90% cure rate.
Line 37: Line 55:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Depend on the type of the [[tumor]] and its potential to produce [[hormonal]]<nowiki/>materials
* Depend on the type of the [[tumor]] and its potential to produce [[hormonal]]<nowiki/>materials
* [[Abdominal pain]] or distention
*[[Abdominal pain]] or distention
* [[Menstrual irregularities]]
*[[Menstrual irregularities]]
* Symptoms of [[virilization]]
* Symptoms of [[virilization]]
* Rapidly growing [[abdominal]]/[[pelvic]] [[mass]]
* Rapidly growing [[abdominal]]/[[pelvic]] [[mass]]
* [[Acute abdominal pain]] from [[complications]] such as:
*[[Acute abdominal pain]] from [[complications]] such as:
* *  [[Necrosis]]
* *  [[Necrosis]]
* * [[Capsule|Capsular]] distention
* * [[Capsule|Capsular]] distention
* [[Rupture|* Rupture]] or [[torsion]] and or simply they can be [[asymptomatic]].
*[[Rupture|* Rupture]] or [[torsion]] and or simply they can be [[asymptomatic]].
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*The majority of [[ovarian]] [[germ cell]][[tumors]] have a [[solid]] and [[cystic]] appearance with areas of [[hemorrhage]]<nowiki/>and [[necrosis]]  
*The majority of [[ovarian]] [[germ cell]][[tumors]] have a [[solid]] and [[cystic]] appearance with areas of [[hemorrhage]]<nowiki/>and [[necrosis]]
* A uniform “fried egg” appearance ([[dysgerminoma]])
* A uniform “fried egg” appearance ([[dysgerminoma]])
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 68: Line 86:
[[Radiotherapy|** Radiotherapy]] is not anymore the first option of treatment for [[dysgerminoma]] considering its association with [[ovarian failure]]<nowiki/>development.
[[Radiotherapy|** Radiotherapy]] is not anymore the first option of treatment for [[dysgerminoma]] considering its association with [[ovarian failure]]<nowiki/>development.


* Surgery: for diagnostic grading and therapy depending on if the patient prefers to preserve the ovary or not.  
* Surgery: for diagnostic grading and therapy depending on if the patient prefers to preserve the ovary or not.


<br />
<br />
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* The 5-year [[survival rate]] of the patient even with [[Disseminated disease|disseminated]][[dysgerminoma]] at the time of [[diagnosis]] is above 90%.  
* The 5-year [[survival rate]] of the patient even with [[Disseminated disease|disseminated]][[dysgerminoma]] at the time of [[diagnosis]] is above 90%.
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 82: Line 100:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="6;" | Extragonadal
| rowspan="6;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" | Extragonadal


| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"| Embryonic
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" | Embryonic
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 92: Line 110:
*
*
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |  
Teratoma
Teratoma
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Chest pain]]
*[[Chest pain]]
* [[Cough]]
*[[Cough]]
* [[Shortness of breath]]
*[[Shortness of breath]]
* [[Abdominal pain]]
*[[Abdominal pain]]
* [[Lump]], Abdominal(ovarian teratoma)
*[[Lump]], Abdominal(ovarian teratoma)
* Abnormal [[bleeding]] from the vagina
* Abnormal [[bleeding]] from the vagina
* [[Fatigue]], [[weight loss]]
*[[Fatigue]], [[weight loss]]
* Limited ability to tolerate exercise
* Limited ability to tolerate exercise
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Teratomas belong to a class of tumors known as [[Nonseminoma|nonseminomatous]] [[germ cell tumor]] (NSGCT).
* Teratomas belong to a class of tumors known as [[Nonseminoma|nonseminomatous]] [[germ cell tumor]] (NSGCT).
* All tumors of this class are the result of abnormal development of [[pluripotent]] cells: [[Germ cell|germ cells]] and [[Embryo|embryonal cells]].  
* All tumors of this class are the result of abnormal development of [[pluripotent]] cells: [[Germ cell|germ cells]] and [[Embryo|embryonal cells]].
* Teratomas of embryonal origin are [[Congenital disorder|congenital]]; teratomas of germ cell origin may or may not be congenital (this is not known).
* Teratomas of embryonal origin are [[Congenital disorder|congenital]]; teratomas of germ cell origin may or may not be congenital (this is not known).
* Embryonal teratomas most commonly occur in the sacrococcygeal region: [[sacrococcygeal teratoma]] is the single most common tumor found in [[Infant|newborn babies]].
* Embryonal teratomas most commonly occur in the sacrococcygeal region: [[sacrococcygeal teratoma]] is the single most common tumor found in [[Infant|newborn babies]].
Line 130: Line 148:
|-
|-


| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"|  
| rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |  
Extraembryonic
Extraembryonic
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 156: Line 174:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-


|}
|}
<references />
<references />

Revision as of 14:15, 8 August 2019

  • Ovarian germ cell tumors (OGCTs ): The histologic types that arise from the ovary are similar to those arising from the testes of men
  • * Embryo-like neoplasms
  • ** Teratomas and their subtypes and
  • ** Dysgerminomas
  • * Extraembryonic fetal-derived (placenta-like) cell populations
  • * A mixture of both.







Types Subtypes Signs and Symptoms Histopathology Lab finding Treatment Prognosis
Gonadal

Seminoma (Testis)

Gross: pale gray to yellow nodules that are uniform or slightly lobulated and often bulge from the cut surface
  • Complete blood count and blood chemistry tests.
  • Abnormal serum tumor marker levels (LDH, HCG).[1]
  • CT: Metastases to the para-aortic, inguinal, or iliac lymph nodes. Visceral metastasis may also be seen.
  • Pelvic MRI: may be diagnostic. multinodular tumors of uniform signal intensity
  • Hypo- to isointense on T2-weighted images and inhomogenous enhancement on contrast enhanced T1-weighted images.
  • Other diagnostic studies for seminoma include biopsy, FDG-PET scan, and bone scan.

Dysgerminoma

(Ovarian germ cell tumor)

  • Chemotherapy: except those with stage 1a, stage 1a, 1b dysgerminoma
  • Radiotherapy:


** Dysgerminoma is radiosensitive.

** Radiotherapy is not anymore the first option of treatment for dysgerminoma considering its association with ovarian failuredevelopment.

  • Surgery: for diagnostic grading and therapy depending on if the patient prefers to preserve the ovary or not.


Germinoma (Brain)

Extragonadal Embryonic

Teratoma

  • AFP
  • MSAFP
  • CT scans are often used to diagnose teratoma.


  • For malignant teratomas, usually, surgery is followed by chemotherapy.
  • Teratomas that are in surgically inaccessible locations, or are very complex, or are likely to be malignant (due to late discovery and/or treatment) sometimes are treated first with chemotherapy.


The prognosis of teratoma depends on the following:

  • Whether or not the tumor can be removed by surgery.
  • The size and location of the tumor
  • The patient’s general health
  • Teratomas are not dangerous for the fetus unless there is either a mass effect or a large amount of blood flow through the tumor (known as vascular steal). The mass effect frequently consists of obstruction of normal passage of fluids from surrounding organs. The vascular steal can place a strain on the growing heart of the fetus, even resulting in heart failure, and thus must be monitored by fetal echocardiography. After surgery, there is a risk of regrowth in place, or in nearby organs [1]

Extraembryonic

Coriocarcinoma

Yolk sac tumor